Add Yahoo as a preferred source to see more of our stories on Google. Schizophrenia is a severe, long-term mental health condition that affects about one in 300 people across the globe. Christin Klose ...

Researchers review the future of schizophrenia treatment, highlighting TAAR1 agonists, NMDA enhancers, and the gut-brain axis ...

Milsaperidone is an active metabolite of iloperidone ...

The FDA OKs pill schizophrenia and bipolar disorder treatment with Bysanti, a new atypical antipsychotic approved for adults.

Add Yahoo as a preferred source to see more of our stories on Google. This image provided by Bristol Myers Squibb in October 2024 shows the company's drug Cobenfy, which the U.S. Food and Drug ...

Daybue was turned down for Rett syndrome, and Iloperidone for schizophrenia and bipolar I, with safety and benefit-risk concerns cited in both cases.

It’s a frustration for both doctors who treat patients with schizophrenia and for people living with it: the most effective antipsychotic drugs have side effects, so unpleasant patients would rather ...

Sept. 26 (UPI) --The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday. The drug, generically called Cobenfy, is the first oral ...

The Food and Drug Administration (FDA) approved Bristol Myers Squibb’s schizophrenia drug Cobenfy Thursday — the first new approved drug for the disease in some 30 years. The drug, a combination of ...

In the months after 24-year-old D.J. was diagnosed with schizophrenia, he searched online for answers to questions that felt urgent and existential. Does it get really bad over time? Will I be able to ...

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday. The results underscore the ...